Updated clinical practice guidelines on the use of vaccines to prevent seasonal COVID-19, influenza, and respiratory ...

In the United States, noroviruses are the single most common cause of acute gastroenteritis in adults that results in a visit to the hospital emergency department, and they are second only to ...

This case series presents 4 Florida residents with pancytopenia receiving antineoplastic chemotherapy who developed illnesses likely due to flood water exposure while immunocompromised, after ...

Live-attenuated viral vaccines (LAV) have been used safely for several decades in healthy individuals to protect against diseases with great success. In immunocompromised hosts their use is usually ...

Early in the pandemic, clinicians noticed that certain immunocompromised patients were experiencing persistent SARS-CoV-2 infections, some lasting weeks to months at a time. This raised concerns that ...

Authors propose enhancing awareness of risks, close genomic surveillance and early diagnostic tests for symptomatic contacts as part of clinical management of these patients. *Please mention the ...

Please provide your email address to receive an email when new articles are posted on . Protecting immunocompromised individuals from infections like herpes zoster is an ongoing challenge for every ...

Early in the pandemic, clinicians noticed that certain immunocompromised patients were experiencing persistent SARS-CoV-2 infections, some lasting weeks to months at a time. This raised concerns that ...

Calabrese, Rheumatology: There have been many different concerns brought by patients surrounding COVID vaccines that encompass misinformation to something they read or encountered. It’s important to ...

Preventing SARS-CoV-2 infection in immunocompromised people hasn't gotten any easier as the pandemic trundles on into its fifth year. The monoclonal antibody tixagevimab-cilgavimab (Evusheld) has long ...

“Immunocompromised” is a large bucket — and not all immunocompromising conditions affect a person’s ability to produce antibodies in response to COVID-19 vaccination the same way, research published ...